Gaillard T, Piketty J, Feron JG, Girard N, et al. Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. Br J Cancer 2024 Jan 27. doi: 10.1038/s41416-024-02580.
PMID: 38280968